ישראל -
עברית -
Ministry of Health
אטוזט 10 מג10 מג
organon pharma israel ltd., israel - atorvastatin as calcium trihydrate; ezetimibe - טבליות מצופות פילם - atorvastatin as calcium trihydrate 10 mg; ezetimibe 10 mg - atorvastatin and ezetimibe
ישראל -
עברית -
Ministry of Health
אטוזט 10 מג20 מג
organon pharma israel ltd., israel - atorvastatin as calcium trihydrate; ezetimibe - טבליות מצופות פילם - atorvastatin as calcium trihydrate 20 mg; ezetimibe 10 mg - atorvastatin and ezetimibe
ישראל -
עברית -
Ministry of Health
אטוזט 10 מג40 מג
organon pharma israel ltd., israel - atorvastatin as calcium trihydrate; ezetimibe - טבליות מצופות פילם - atorvastatin as calcium trihydrate 40 mg; ezetimibe 10 mg - atorvastatin and ezetimibe
ישראל -
עברית -
Ministry of Health
אטוזט 10 מג80 מג
organon pharma israel ltd., israel - atorvastatin as calcium trihydrate; ezetimibe - טבליות מצופות פילם - atorvastatin as calcium trihydrate 80 mg; ezetimibe 10 mg - atorvastatin and ezetimibe
ישראל -
עברית -
Ministry of Health
אזטרול 10 מ"ג טבליות
merck sharp & dohme israel ltd - ezetimibe 10 mg - tablets - ezetimibe - primary hypercholesterolemia: ezetrol administered with an hmg-coa reductase inhibitor (statin) or alone are indicated as adjunctive therapy to diet for use in patients with primary (heterozygous familial and non-familial) hypercholesterolemia. homozygous familial hypercholesterolemia (hofh): ezetrol administered with a statin are indicated for use in patients with hofh.patients may also receive adjunctive treatments (e.g. ldl apheresis).homozygous sitosterolemia (phytosterolemia): ezetrol are indicated for use in patients with homozygous familial sitosterolemia.
ישראל -
עברית -
Ministry of Health
אינג'י 10 מ"ג/10 מ"ג טבליות
merck sharp & dohme israel ltd - ezetimibe 10 mg; simvastatin 10 mg - tablets - simvastatin - hypercholesterolemia: inegy is indicated as adjunctive therapy to diet for use in patients with primary ( heterozygous familial and nonfamilial) hypercholesterolemia or mixed hyperlipidemia where use of a combination product is appropriate: - patients not appropriately controlled with a statin alone - patients already treated with a statin and ezetimibe. inegy contains ezetimibe and simvastatin. simvastatin ( 20 - 40 mg ) has been shown to reduce the frequency of cardiovascular events. studies to demonstrate the efficacy of inegy or ezetimibe in the prevention of complications of atherosclerosis have not been completed. homozygous familial hypercholesterolemia (hofh): inegy is indicated as adjunctive therapy to diet for use in patients with hofh.patients may also receive adjunctive treatments ( e.g. low-density lipoprotein [ldl] apheresis).
ישראל -
עברית -
Ministry of Health
אזהאטורבה 10 מג10 מג
novartis israel ltd - atorvastatin as calcium trihydrate; ezetimibe - טבליות מצופות פילם - atorvastatin as calcium trihydrate 10 mg; ezetimibe 10 mg - atorvastatin and ezetimibe
ישראל -
עברית -
Ministry of Health
אזהאטורבה 10 מג20 מג
novartis israel ltd - atorvastatin as calcium trihydrate; ezetimibe - טבליות מצופות פילם - atorvastatin as calcium trihydrate 20 mg; ezetimibe 10 mg - atorvastatin and ezetimibe
ישראל -
עברית -
Ministry of Health
אזהאטורבה 10 מג40 מג
novartis israel ltd - atorvastatin as calcium trihydrate; ezetimibe - טבליות מצופות פילם - atorvastatin as calcium trihydrate 40 mg; ezetimibe 10 mg - atorvastatin and ezetimibe
ישראל -
עברית -
Ministry of Health
אזהאטורבה 10 מג80 מג
novartis israel ltd - atorvastatin as calcium trihydrate; ezetimibe - טבליות מצופות פילם - atorvastatin as calcium trihydrate 80 mg; ezetimibe 10 mg - atorvastatin and ezetimibe